Departamento de Investigación en Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Calz. Tlalpan 4502, Col. Sección XVI, 14080, Mexico City, Mexico.
Hospital de Pediatría, Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Unidad de Investigación Médica en Genética Humana, Av. Cuauhtémoc 330, Col. Doctores, 06720, Mexico City, Mexico.
Lung. 2018 Aug;196(4):393-400. doi: 10.1007/s00408-018-0115-9. Epub 2018 Apr 10.
microRNAs (miRNAs) are small non-coding 1RNAs that post-transcriptionally regulate gene expression. Recent evidence shows that adenosine deaminases that act on RNA (ADAR) can edit miRNAs. miRNAs are involved in the development of different diseases, such as idiopathic pulmonary fibrosis (IPF). In IPF, about 40% of the miRNAs are differentially expressed with respect to controls. Among these miRNAs, miRNA-21 has been found over-expressed in IPF and its targets are anti-fibrosing molecules such as PELI1 and SPRY2. The objective of this study is to determine the role of ADAR1 and 2 on the expression of miRNA-21 in human lung fibroblasts trough quantification of gene expression, protein levels, and overexpression of ADAR1 and 2.
Six control and six fibrotic primary fibroblast cell cultures were used for RNA extraction, ADAR1, ADAR2, PELI1, SPRY2, miRNA-21, and pri-miRNA-21 expression was measured. Subsequently, two fibrotic fibroblast cultures were used for overexpression of ADAR1 and ADAR2, and they were stimulated with TGFβ1. Real-time PCR and Western blot were performed.
ADAR1 is significantly downregulated in IPF fibroblasts; the overexpression of ADAR1 and ADAR2 reestablishes the expression levels of miRNA-21, PELI1, and SPRY2 in fibroblasts of patients with IPF.
These changes in the processing of miRNAs have great value in pathology diagnosis, including lung diseases, and play an important role in the understanding of molecular mechanisms involved in the development of different pathologies, as well as representing new therapeutic targets.
微小 RNA(miRNA)是一种小的非编码 RNA,可在后转录水平上调节基因表达。最近的证据表明,作用于 RNA 的腺苷脱氨酶(ADAR)可以编辑 miRNA。miRNA 参与了多种疾病的发生,如特发性肺纤维化(IPF)。在 IPF 中,大约 40%的 miRNA 与对照相比表达不同。在这些 miRNA 中,miRNA-21 在 IPF 中表达过度,其靶标是抗纤维化分子,如 PELI1 和 SPRY2。本研究的目的是通过定量检测基因表达、蛋白水平以及 ADAR1 和 2 的过表达,来确定 ADAR1 和 2 对人肺成纤维细胞中 miRNA-21 表达的作用。
使用 6 个对照和 6 个纤维化原代成纤维细胞培养物进行 RNA 提取,检测 ADAR1、ADAR2、PELI1、SPRY2、miRNA-21 和 pri-miRNA-21 的表达。随后,用 TGFβ1 刺激 2 个纤维化成纤维细胞培养物,过表达 ADAR1 和 ADAR2,并进行实时 PCR 和 Western blot。
ADAR1 在 IPF 成纤维细胞中显著下调;ADAR1 和 ADAR2 的过表达恢复了 IPF 患者成纤维细胞中 miRNA-21、PELI1 和 SPRY2 的表达水平。
这些 miRNA 处理的变化在病理学诊断中具有重要价值,包括肺部疾病,并在理解不同病理学发展中的分子机制方面发挥着重要作用,代表着新的治疗靶点。